Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:bavarian_nordic [2022/06/21 01:42]
liam
+++ pharmaceutical_companies:bavarian_nordic [2022/07/07 09:09] (current)
liam [Biosecurity]
@@ Line 7: / Line 7: @@
 ===== History =====
-On May 6, 2022, the company was awarded a contract by the [[:Public Health Agency of Canada]] (PHAC) to provide 500,000 units of Imvamune to the Canadian stockpile. The tender announcement described the purchase as being in anticipation of a potential accidental or intentional release of [[:smallpox]].
+On May 6, 2022, the company was awarded a contract by the [[:Public Health Agency of Canada]] (PHAC) to provide 500,000 units of Imvamune to the Canadian stockpile.((Public Services and Procurement Canada. (2022, April 21). //Third Generation Smallpox Vaccine (6D024-215700/A).// Government of Canada. https://web.archive.org/web/20220620184646/https://buyandsell.gc.ca/procurement-data/tender-notice/PW-PH-893-81160)) The tender announcement described the purchase as being in anticipation of a potential accidental or intentional release of [[:smallpox]].((Osman, L. (2022, May 20). //Canada considering smallpox vaccine for monkeypox cases, says Dr. Theresa Tam.// CTV News. https://archive.ph/HiTkL))
+===== Affiliations =====
+==== Biosecurity ====
+Bavarian Nordic is a funding partner of the [[:Bipartisan Commission on Biodefense]].((//Sponsors / Donors.// Bipartisan Commission on Biodefense. Retrieved May 28, 2022, from https://archive.ph/bplYy))
+Additionally, the company is a funding partner of the [[:Alliance for Biosecurity]],((//Who we are.// Alliance for Biosecurity. Retrieved June 20, 2022, from https://archive.ph/FaOGm)) and former donor to the [[:Bipartisan Policy Center]].((//2017 Annual Report.// (2017). Bipartisan Policy Center. https://web.archive.org/web/20220707070050/https://bipartisanpolicy.org/download/?file=%2Fwp-content%2Fuploads%2F2019%2F07%2FAnnual-Report-2017.pdf))
 ===== Products =====